Spotify founder Daniel Ek’s health startup Neko Health raised $700 million in a Series C round, boosting its proprietary body‑scanning platform that combines imaging with blood tests and Apple Health data. The funding paves the way for a New York launch and broader consumer adoption.

Key Takeaways

  • Neko Health raises $700 million in Series C funding
  • Proprietary body‑scanning tech integrates imaging, blood work and Apple Health data
  • Preparing to open first U.S. clinic in New York

Neko Health is a fast‑growing health‑tech startup founded by Spotify co‑founder Daniel Ek and Hjalmar Nilsonne. The company just closed a $700 million Series C round led by Lightspeed Venture Partners and O.G. Venture Partners, following a $260 million Series B raised in January 2025.

Background and Growth

With locations already operating in the United Kingdom and Sweden, Neko Health has deployed its proprietary body‑scanning platform that fuses advanced imaging, blood‑test analytics and personal data from Apple Health. For fitness enthusiasts, the scan now also delivers detailed body‑composition metrics, broadening its appeal beyond traditional medical diagnostics.

Significance of the Funding

The round attracted heavyweight investors such as Lightspeed, O.G. Venture Partners, Atomico, General Catalyst, Lakestar, Liberty City Ventures, Positive Sum, and BDT & MSD. The capital will not only accelerate product development but also fund the launch of the company’s first U.S. site in New York City. To date, more than 100,000 individuals have undergone scans, and over 350,000 people are either on the waiting list or have booked appointments.

Consumer Impact and Notable Cases

Calm founder Alex Tew shared on X that a Neko Health scan detected a malignant mole on his back, which was promptly removed. Stories like this underscore the platform’s potential to catch serious conditions early, reinforcing confidence among users and clinicians alike.

Future Outlook

As artificial intelligence and biotech converge, Neko Health’s hybrid diagnostic model could set a new benchmark for preventive health services. If the company succeeds in turning raw scan data into actionable clinical insights, it may not only improve individual outcomes but also reshape the broader healthcare delivery ecosystem.